Christine S. Rollier
Post-doctoral research associate
- Jenner Investigator
- James Martin fellow
Christine Rollier is a post-doctoral senior research scientist at the Oxford Vaccine Group. She studied biochemistry and obtained her PhD at the University of Lyon I in 2000, studying DNA immunization as a therapeutic approach against chronic Hepatitis B Virus infection. She trained in immunology, specialising in vaccine development at Institut National de la Sante et Recherche Medicale (INSERM), Lyon, France. She proceeded to work on novel vaccine development against Hepatitis C Virus chronic infection at the Biomedical Primate Research Center, The Netherlands for five years, before joining the Jenner Institute at the University of Oxford in 2007 as a senior immunologist to work on improvements of vaccine vectors against malaria. She started her current position at the Oxford Vaccine group in 2010, and her research activities, funded by the Oxford Biomedical Research Centre, Medical Research Council and charities, include pre-clinical and clinical investigation of new and improved vaccines against bacterial infections such as serogroup B meningococcus.
Christine is also a James Martin Fellow and a Jenner Investigator.
The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.
Diemen PMV. et al, (2017), Sci Rep, 7, 1745 - 1745
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.
Giuntini S. et al, (2017), Clin Vaccine Immunol, 24
Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.
Rollier CS. et al, (2016), Vaccine
Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion.
Whitehouse J. et al, (2016), Vaccine, 34, 1792 - 1799
Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
Daniels-Treffandier H. et al, (2016), PLoS One, 11